ResearcherSun Yat-sen University Cancer CenterActive in the last 2 years

Ran Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-2395-1692; OpenAlex author ID A5034863656. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis. Last author DOI 10.1186/s12885-025-13824-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shengping Li · 1 shared paper, 2025 · strength 0.28
- Paper Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian … DOI 10.1186/s12885-025-13824-7 ↗
Dailei Qin · 1 shared paper, 2025 · strength 0.28
- Paper Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian … DOI 10.1186/s12885-025-13824-7 ↗
Zehui Yao · 1 shared paper, 2025 · strength 0.28
- Paper Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian … DOI 10.1186/s12885-025-13824-7 ↗
Pu Xi · 1 shared paper, 2025 · strength 0.28
- Paper Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian … DOI 10.1186/s12885-025-13824-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.